Bâle (ots) - Oettinger Davidoff AG a inauguré aujourd'hui la Maison Davidoff, sise Nauenstrasse 73 à ...
Animal Pharm Industry Awards assigned in London: Prionics nominated as a best in class Animal Health Company
Zurich (ots) - Prionics, the world leader in BSE and prion testing, has been recognized for its contribution to animal health and food safety. After being awarded with the European Biotech Award 2004, the nomination for the Animal Pharm Industry Awards honors the achievements of the Swiss biotech company in successfully expanding its solution portfolio for the early diagnosis of major farm animal diseases. Today, Prionics ranks among the top three global companies in farm animal diagnostics.
The first Animal Pharm Industry Excellence Awards (www.animalpharmawards.com) held in London on October 12, 2006, has identified best in class companies across the animal health industries. The prize honors outstanding achievements, judging innovation, performance, product pipeline, new drug launches and financial return. "Being considered to be among the three best in class animal health companies of the world and ranking on a level with renowned companies such as Pfizer Animal Health is a tremendous honour for Prionics. It confirms that our strategy to focus on major farm animal health issues and grow our diagnostic portfolio accordingly is working and that our solutions deliver a competitive edge in the market", says Dr Markus Moser, CEO of Prionics.
Prionics Among Top 3 Global Players
Food safety by eliminating diseases early in the food chain is growing in importance and market potential as it directly affects disease prevention in human health management. Within ten years of being formed, Prionics ranks among the three leading global diagnostic players in farm animal health. The Swiss biotech company intends to further develop its core business by creating diagnostic solutions in its own R&D facilities and laboratories in Zurich as well as through collaborations and acquisitions.
Building on an extensive scientific network with leading research institutes around the world, earlier this year Prionics acquired CEDI Diagnostics B.V. and signed a strategic partnership with the Animal Science Group of Wageningen (Netherlands), a recognized leader in animal disease control. With these latest moves the company has further expanded its portfolio with tests proven on the market and gained access to a unique research and competence centre.
Prionics is the world leader in the diagnosis of BSE and other prion diseases. Founded in 1997 as a spin-off from Zurich University and headquartered in Zurich, Prionics develops and markets diagnostic products for the early diagnosis of farm animal diseases. The company places its main focus on diseases which are transmissible from animals to human beings and thereby contributing to an improvement to food safety. In October 2005 Prionics acquired Pfizer Animal Health's Diagnostic portfolio. The recipient of the Swiss Economic Award 2002 as "Company of the year" and winner of the European Biotech Award 2004 for Excellence in Biotech Business; Prionics is driving its business through a combination of outstanding research, high-quality products and innovative market solutions.
ots Originaltext: Prionics AG